Translational dysregulation in cancer: molecular insights and potential clinical applications in biomarker development
C Vaklavas, SW Blume, WE Grizzle - Frontiers in oncology, 2017 - frontiersin.org
Although transcript levels have been traditionally used as a surrogate measure of gene
expression, it is increasingly recognized that the latter is extensively and dynamically …
expression, it is increasingly recognized that the latter is extensively and dynamically …
Eukaryotic initiation factor 4E (eIF4E): A recap of the cap‐binding protein
A Batool, S Aashaq, KI Andrabi - Journal of cellular …, 2019 - Wiley Online Library
Eukaryotic initiation factor 4E (eIF4E), a fundamental effector and rate limiting element of
protein synthesis, binds the 7‐methylguanosine cap at the 5′ end of eukaryotic messenger …
protein synthesis, binds the 7‐methylguanosine cap at the 5′ end of eukaryotic messenger …
Expression of semaphorin 3A, semaphorin 7A and their receptors in multiple sclerosis lesions
C Costa, E Martínez-Sáez… - Multiple Sclerosis …, 2015 - journals.sagepub.com
Background: Studies in multiple sclerosis (MS) and in experimental models point to a critical
role of semaphorin (sema) 3A and sema7A in MS pathogenesis. Objective: The objective of …
role of semaphorin (sema) 3A and sema7A in MS pathogenesis. Objective: The objective of …
[HTML][HTML] Separation of low and high grade colon and rectum carcinoma by eukaryotic translation initiation factors 1, 5 and 6
N Golob-Schwarzl, C Schweiger, C Koller, S Krassnig… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Colorectal cancer (CRC) is the third most common cause of cancer related death worldwide.
Furthermore, with more than 1.2 million cases registered per year, it constitutes the third …
Furthermore, with more than 1.2 million cases registered per year, it constitutes the third …
Prognostic significance of eukaryotic initiation factor 4E in hepatocellular carcinoma
XM Jiang, XN Yu, RZ Huang, HR Zhu, XP Chen… - Journal of cancer …, 2016 - Springer
Purpose Aberrant expression of eukaryotic initiation factor 4E (eIF4E) has been observed in
human malignancies. However, its role in hepatocellular carcinoma (HCC) remains to be …
human malignancies. However, its role in hepatocellular carcinoma (HCC) remains to be …
Overexpression of eIF4E in colorectal cancer patients is associated with liver metastasis
T Xu, Y Zong, L Peng, S Kong, M Zhou… - OncoTargets and …, 2016 - Taylor & Francis
Purpose Liver metastasis is one of the leading causes of death in colorectal cancer (CRC)
patients. The present study aimed to evaluate the value of eIF4E as a prognostic marker of …
patients. The present study aimed to evaluate the value of eIF4E as a prognostic marker of …
Cell fate control by translation: mRNA translation initiation as a therapeutic target for cancer development and stem cell fate control
HJ Kim - Biomolecules, 2019 - mdpi.com
Translation of mRNA is an important process that controls cell behavior and gene regulation
because proteins are the functional molecules that determine cell types and function …
because proteins are the functional molecules that determine cell types and function …
Identification of gene signature as diagnostic and prognostic blood biomarker for early hepatocellular carcinoma using integrated cross-species transcriptomic and …
Background: Hepatocellular carcinoma (HCC) is considered the most common type of liver
cancer and the fourth leading cause of cancer-related deaths in the world. Since the disease …
cancer and the fourth leading cause of cancer-related deaths in the world. Since the disease …
Eukaryotic translation initiation factor 4E (eIF-4E) expressions are associated with poor prognosis in colorectal adenocarcinoma
YT Chen, HP Tsai, CC Wu, JY Wang… - Pathology-Research and …, 2017 - Elsevier
Both phosphorylated 4E binding protein 1 (p-4E-BP1) and eukaryotic translation initiation
factor 4E (eIF-4E) play an important role in cancer progression. The aim of this study is to …
factor 4E (eIF-4E) play an important role in cancer progression. The aim of this study is to …
Increased phosphorylation of 4E‑binding protein 1 predicts poor prognosis for patients with colorectal cancer
Y Miao, L Chen, C Shi, R Fan… - Molecular …, 2017 - spandidos-publications.com
As demonstrated in previous studies, the phosphorylated form of 4E‑binding protein 1 (p‑4E‑
BP1) may be a suitable tumor biomarker. The aim of the current study was to examine the …
BP1) may be a suitable tumor biomarker. The aim of the current study was to examine the …